The Effects of Oral Microbiome on Systemic Health

Abstract

The oral microbiome, a diverse community of microorganisms, plays a critical role in maintaining oral and systemic health. Disruptions in this microbiome, known as dysbiosis, are associated with oral diseases like dental caries and periodontitis, as well as systemic conditions such as diabetes, cardiovascular disease or cancer. The oral microbiota varies across individuals and within different regions of the oral cavity, influenced by factors like oxygen levels, nutrient content, and immune response. Emerging research highlights the microbiome's potential role in conditions like stunting in children and neurodegenerative diseases. The oral microbiome is also linked to systemic diseases. For example, oral bacteria have been detected in the lungs of cystic fibrosis patients and are associated with respiratory infections like pneumonia. In gastrointestinal diseases, oral microbiome imbalances are linked to conditions such as inflammatory bowel disease (IBD) Additionally, endocrine disorders like diabetes and obesity show strong correlations with oral microbiome changes. Maintaining a balanced oral microbiome is crucial for preventing and managing these diseases. Treatment strategies must focus on preserving the microbiome's integrity while targeting pathogenic bacteria. As research continues to uncover the complex relationships between oral health and systemic diseases, interdisciplinary collaboration between dentistry and medicine will be key to advancing preventive and therapeutic approaches.

Keywords:

Oral microbiome, systemic disease, health, prevention

References

Seymour B. Global Oral Health. Journal of the California Dental Association. 2024 52(1).

Alpert PT. Oral Health. Home Health Care Manag Pract. 2017 Feb 9;29(1):56–9.

Kotan MH, Babacan M, Çadırcı M, Özakar N, Oral Hijyen ve Diyetin Agiz Hastaliklari ve Genel Saglik Uzerindeki Etkileri. Dis Hekimliginde Guncel Tanisal Terapotik ve Koruyucu Yaklasimlar. In: KOÇAK TOPBAŞ N, editor. Ankara: UBAK Yayınevi. 2024. pp.1-30.

Chowdhry A, Kapoor P, Bhargava D, Bagga DK. Exploring the oral microbiome: an updated multidisciplinary oral healthcare perspective. Discoveries. 2023, 11(2): e165. doi: 10.15190/d.2023.4.

Santonocito S, Giudice A, Polizzi A, Troiano G, Merlo EM, Sclafani R, et al. A cross-talk between diet and the oral microbiome: balance of nutrition on inflammation and immune system’s response during periodontitis. Nutrients. 2022, 14(12):2426. doi: 10.3390/nu14122426.

Tjandrawinata RR, Amalia N, Tandi YYP, Athallah AF, Afif Wibowo C, Aditya MR, Muhammad AR, Azizah MR, Humardani FM, Nojaid A, Christabel JA, Agnuristyaningrum A and Nurkolis F. The forgotten link: how the oral microbiome shapes childhood growth and development. Front. Oral. Health. 2025, 6:1547099. doi: 10.3389/froh.2025.1547099.

Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol, 2018. 200(4): p. 525-540.

Kulekci G. Agiz Sağliginin Yeni Tanimi: Agiz Mikrobiyomu. Ankem Dergi, 2013. 27(3):167-172.

The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature, 2012. 486(7402): p. 207-14.

He J, Li Y, Cao Y, Xue J, Zhou X. The oral microbiome diversity and its relation to human diseases. Folia Microbiol (Praha). 2015 Jan;60(1):69-80. doi: 10.1007/s12223-014-0342-2. Epub 2014 Aug 23. PMID: 25147055.

Yamazaki K, Kamada N. Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases. Mucosal Immunology, 2024, 17(1):147-153.

Pamukçu U, Yıldız FN, Dal T, Peker İ. Oral Mikrobiyota Araştırmaları Işığında Ağız Sağlığına Yeni Bakış Açısı: Derleme. 2018, 2:128-137.

Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Kehagia V, Connett GJ, Bruce KD. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol. 2006 Jul;44(7):2601-4. doi: 10.1128/JCM.02282-05. PMID: 16825392; PMCID: PMC1489498.

Boonanantanasarn KG. The oral microbiome, in oral microbial communities: genomic inquiry and interspecies communication, Kolenbrander PE, Editor. 2011, ASM Press: Washington, DC.

Kurtaran B. Microbiome and microbiota. Ege Journal of Medicine 2021; 60: Supplement 88-93.

Haznedaroglu E, Polat E. Dental Caries, Dental Erosion and Periodontal Disease in Children with Inflammatory Bowel Disease. Int J Med Sci. 2023 Apr 9;20(5):682-688. doi: 10.7150/ijms.83075.PMID: 37082734; PMCID: PMC10110475.

Docktor MJ, Paster BJ, Abramowicz S, Ingram J, Wang YE, Correll M, Jiang H, Cotton SL, Kokaras AS, Bousvaros A. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2012 May;18(5):935-42. doi: 10.1002/ibd.21874. Epub 2011 Oct 10. PMID: 21987382; PMCID: PMC4208308.

Riviere GR, Riviere KH, KS Smith. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol, 2002. 17(2):13-8.

Pereira PAB, Aho VTE, Paulin L, Pekkonen E, Auvinen P, Scheperjans F. Oral and nasal microbiota in Parkinson's disease. Parkinsonism Relat Disord. 2017 May; 38:61-67. doi: 10.1016/j.parkreldis.2017.02.026. Epub 2017 Feb 22. PMID: 28259623.

Soiniemi L, Solje E, Suominen AL, Kanninen KM, Kullaa AM. The association between oral diseases and neurodegenerative disorders. Journal of Alzheimer’s Disease. 2024;102(3):577-586.

Gao L, Xu T, Huang G, Jiang S, Gu Y, Chen F. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell. 2018 May;9(5):488-500. doi: 10.1007/s13238-018-0548-1. Epub 2018 May 7. PMID: 29736705; PMCID: PMC5960472.

Murodullayevich TO, G’ayrat qizi UJ, Abdunosirovich RR, Bakhiyorovna RS. Dental Diseases Caused by Hormonal Changes in The Body. WEJMMS. 2024 Feb. 24;2(2):29-31.

Clemente-Suárez VJ, Redondo-Flórez L, Rubio-Zarapuz A, Martín-Rodríguez A, Tornero-Aguilera JF. Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches. Biomedicines. 2024; 12(1):221.

Ussar SS, Fujisaka C, Kahn CR, Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome. Mol Metab, 2016, 5(9):795-803.

Goodson JM, Groppo D, Halem S, Carpino E. Is obesity an oral bacterial disease? J Dent Res. 2009 Jun;88(6):519-23. doi: 10.1177/0022034509338353. PMID: 19587155; PMCID: PMC2744897.

MADIANOS, P.N., Y.A. BOBETSIS, and S. OFFENBACHER, Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J Periodontol, 2013. 84(4 Suppl): p. S170-80.

VIATTE, S., D. PLANT, and S. RAYCHAUDHURI, Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol, 2013. 9(3): p. 141-53.

Lange L, Thiele GM, McCracken C, Wang G, Ponder LA, Angeles-Han ST, Rouster-Stevens KA, Hersh AO, Vogler LB, Bohnsack JF, Abramowicz S, Mikuls TR, Prahalad S. Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016 Feb 9;14(1):8. doi: 10.1186/s12969-016-0068-6. PMID: 26861944; PMCID: PMC4748489.

Kholy KE, Genco RJ, Van Dyke TE. Oral infections and cardiovascular disease. Trends Endocrinol Metab. 2015 Jun;26(6):315-21. doi: 10.1016/j.tem.2015.03.001. Epub 2015 Apr 16. PMID: 25892452.

Men B, Li Y, Jiang S. Updates on the Role of Periodontitis-Related Epigenetics, Inflammation, Oral Microbiome, and Treatment in Cardiovascular Risk. J Inflamm Res. 2024 Feb 7;17:837-851. doi: 10.2147/JIR.S449661. PMID: 38344306; PMCID: PMC10859091.

Leonov G, Salikhova D, Starodubova A, Vasilyev A, Makhnach O, Fatkhudinov T, Goldshtein D. Oral Microbiome Dysbiosis as a Risk Factor for Stroke: A Comprehensive Review. Microorganisms. 2024 Aug 22;12(8):1732. doi: 10.3390/microorganisms12081732. PMID: 39203574; PMCID: PMC11357103.

Atarbashi-Moghadam F, Havaei SR, Havaei SA, Hosseini NS, Behdadmehr G, Atarbashi-Moghadam S. Periopathogens in atherosclerotic plaques of patients with both cardiovascular disease and chronic periodontitis. ARYA Atheroscler. 2018 Mar;14(2):53-57. doi: 10.22122/arya.v14i2.1504. PMID: 30108636; PMCID: PMC6087625.

Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev. 2008 Feb;18(1):3-10. doi: 10.1016/j.gde.2008.01.003. Epub 2008 Mar 5. PMID: 18325755.

Belibasakis GN, Seneviratne CJ, Jayasinghe RD, Vo PT, Bostanci N, Choi Y. Bacteriome and mycobiome dysbiosis in oral mucosal dysplasia and oral cancer. Periodontol 2000. 2024 Oct;96(1):95-111. doi: 10.1111/prd.12558. Epub 2024 Mar 19. PMID: 38501658; PMCID: PMC11579824.

Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009 Sep;31(9):1228-39. doi: 10.1002/hed.21140. PMID: 19475550.

Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, Paster BJ, Joshipura K, Wong DT. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012 Apr;61(4):582-8. doi: 10.1136/gutjnl-2011-300784. Epub 2011 Oct 12. PMID: 21994333; PMCID: PMC3705763.

Tian S, Ding T, Li H. Oral microbiome in human health and diseases. mLife. 2024 Sep 16;3(3):367-383. doi: 10.1002/mlf2.12136. PMID: 39359681; PMCID: PMC11442140.